Coston McIsaac & Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.69M Buy
59,948
+2,650
+5% +$214K 0.94% 32
2026
Q1
$4.96M Sell
57,298
-219
-0.4% -$21K 1.12% 30
2025
Q4
$5.52M Buy
57,517
+1,496
+3% +$145K 1.28% 26
2025
Q3
$5.33M Buy
56,021
+142
+0.3% +$13.1K 1.27% 28
2025
Q2
$4.87M Buy
55,879
+307
+0.6% +$26K 1.26% 27
2025
Q1
$4.99M Buy
55,572
+525
+1% +$47K 1.46% 24
2024
Q4
$4.4M Sell
55,047
-1,123
-2% -$97.2K 1.3% 26
2024
Q3
$5.06M Buy
56,170
+1,580
+3% +$133K 1.43% 29
2024
Q2
$4.3M Buy
54,590
+1,204
+2% +$98.7K 1.35% 29
2024
Q1
$4.65M Buy
53,386
+1,697
+3% +$145K 1.49% 27
2023
Q4
$4.26M Buy
51,689
+2,938
+6% +$224K 1.48% 27
2023
Q3
$3.82M Buy
48,751
+4,471
+10% +$374K 1.45% 28
2023
Q2
$3.9M Buy
44,280
+2,094
+5% +$180K 1.34% 30
2023
Q1
$3.4M Buy
42,186
+6,882
+19% +$561K 1.27% 33
2022
Q4
$2.74M Sell
35,304
-295
-0.8% -$23.9K 1.07% 35
2022
Q3
$2.87M Buy
35,599
+5,652
+19% +$508K 1.31% 31
2022
Q2
$2.69M Buy
+29,947
New +$3.03M 1.62% 31

Other funds holding MDT

Coston McIsaac & Partners's MDT Position: Q2 2026 in Review

Coston McIsaac & Partners increased its Medtronic (MDT) stake by 4.6% in Q2 2026, buying an estimated $214K and bringing the position to 59,948 shares worth $4.69M. The position accounts for 0.94% of the portfolio, ranked #32.

Coston McIsaac & Partners first reported a position in MDT in Q2 2022 and has held it in 17 quarters since. The position peaked at $5.52M in Q4 2025. 2,132 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Coston McIsaac & Partners held 59,948 shares of Medtronic worth $4.69M as of Q2 2026.
  • Coston McIsaac & Partners bought 2,650 Medtronic shares in Q2 2026, an estimated $214K.
  • Medtronic made up 0.94% of Coston McIsaac & Partners's portfolio in Q2 2026, its #32 holding.
  • Coston McIsaac & Partners first reported a position in Medtronic in Q2 2022 and has held it in 17 quarters since.
  • Coston McIsaac & Partners's Medtronic position peaked at $5.52M in Q4 2025.
  • 2,132 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Coston McIsaac & Partners's 13F filing for Q2 2026, filed 12 Aug 2026.